We are delighted to announce that Ikris Pharma Network (IPN) will be participating in the much-anticipated CPHI Middle East 2024. This iconic pharmaceutical event in Riyadh will take place from…
In the ever-evolving landscape of healthcare, access to specialty medicines has become a critical factor in treating complex and chronic diseases. These high-cost, high-complexity drugs are used to manage conditions…
Over-the-counter medicines are everyday essentials that help us tackle minor health issues without needing a prescription. Whether it’s soothing a headache or relieving a stuffy nose, these readily available remedies…
Clinical trials are the backbone of medical advancement, offering hope for new treatments and therapies across a range of diseases. These trials require a meticulous and complex process to ensure…
In the complex landscape of global healthcare, access to essential medicines is a critical issue, especially for patients who require treatments that are not yet approved in their home countries.…
In the dynamic and rapidly evolving pharmaceutical industry, Europe has emerged as a key player in the global market. Among the various companies that have made a significant mark, Ikris…
In today’s globalized world, the demand for quality pharmaceuticals is ever-increasing. For many countries, especially in Europe, Latin America, and Africa, reliable pharmaceutical exporters play a crucial role in ensuring…
The process of importing unlicensed medicines through Named Patient Services involves several critical steps, each requiring meticulous attention to detail and adherence to regulatory standards...
In the evolving landscape of global healthcare, access to critical medicines remains a significant challenge, particularly for patients with rare or life-threatening conditions. Named Patient Medicine Programs (NPPs) have emerged…
The success of clinical trials depends on having high-quality pharmaceutical products. At Ikris Pharma Network, we are committed to bridging the gaps in clinical trial drug sourcing. We ensure researchers…
